MedTrace Logo

The Impact of Bariatric Surgery on Non-alcoholic Fatty Liver Disease

NCT02828579 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2019-09-12

No results posted yet for this study

Summary

Up to 300 million people have a BMI over 30kg/m2. Obesity is the cause of many serious diseases, such as type 2 diabetes, hypertension and NAFLD. Bariatric surgery is the only effective method of achieving weight loss in patients with morbid obesity.

The aim of the study is to assess the impact of bariatric surgery on non-alcoholic fatty liver disease in patients operated on due to morbid obesity.

Conditions

Interventions

PROCEDURE

Bariatric surgery

Laparoscopic Sleeve Gastrectomy (LSG) Laparoscopic Roux-en-Y Gastric Bypass (LRYGB)

Sponsors & Collaborators

  • Jagiellonian University

    lead OTHER

Principal Investigators

  • Piotr Major, MD, PhD · 2'nd Department of General Surgery, Jagiellonian University Medical College

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2016-01-31
Completion
2016-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02828579 on ClinicalTrials.gov